PA
SEM

Paralel Advisors’s Select Medical SEM Stock Holding History

Paralel Advisors’s Portfolio SEM Stock Details SEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-137,309
Closed -$2.23M – 128
2024
Q1 		$2.23M Hold
137,309
– – 0.1% 62
2023
Q4 		$1.74M Hold
137,309
– – 0.09% 82
2023
Q3 		$1.87M Buy
137,309
+1,552
+1% +$24K 0.1% 53
2023
Q2 		$2.33M Sell
135,757
-4,883
-3% -$75.7K 0.12% 30
2023
Q1 		$1.96M Buy
140,640
+3,697
+3% +$54.4K 0.11% 40
2022
Q4 		$1.83M Buy
+136,943
New +$1.77M 0.11% 41

Other funds holding SEM

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Paralel Advisors's SEM Position: Q2 2024 in Review

Paralel Advisors sold out of Select Medical (SEM) in Q2 2024, closing a stake of 137,309 shares — an estimated $2.23M sold.

Paralel Advisors first reported a position in SEM in Q4 2022 and held it in 6 quarters. The position peaked at $2.33M in Q2 2023. 256 funds tracked by Wall St. Rank hold SEM as of Q2 2024.

  • Paralel Advisors reported no remaining Select Medical position as of Q2 2024 after selling out during the quarter.
  • Paralel Advisors sold 137,309 Select Medical shares in Q2 2024, an estimated $2.23M.
  • Paralel Advisors first reported a position in Select Medical in Q4 2022 and held it in 6 quarters.
  • Paralel Advisors's Select Medical position peaked at $2.33M in Q2 2023.
  • 256 funds tracked by Wall St. Rank held Select Medical as of Q2 2024.

Based on Paralel Advisors's 13F filing for Q2 2024, filed 6 Aug 2024.